Antares COVID-19 Statement

Antares Health Products, Inc. continues serving customers during the pandemic.

The coronavirus pandemic continues to present major challenges to all of us. I am very pleased to inform all our customers that, with full attendance to health and safety, the Antares Team has been able to meet their needs with adequate inventory, timely delivery, and the high quality customer and technical service they have come to expect.

The Antares Team strives to continue providing the highest level of service for the duration of the pandemic and beyond. Its efforts include additional production and inventory of NF (Pharmaceutical Grade) and FG (Food Grade) in both regular TPGS and Sunflower TPGS™ (non-GMO). We are in close collaboration with customers to meet their short and long-term needs.

The coronavirus pandemic dramatically increased our customer’s need for expedited product formulation, development, clinical testing, and regulatory approval of health products. Antares Health Products, Inc. strengthened its team, increased its capabilities, and will continue working very closely with our customers in all these areas. The Antares Vitamin E TPGS Type IV Drug Master File (DMF #28188) and the synergies with our international partners enabled the Antares Team to provide major assistance to our customers both in the United States and internationally.

The Antares Team has been gratified with the positive customer feedback and welcomes your inquiries and comments. Please be safe and stay healthy.

Andreas M Papas, PhD
CEO